Diabetes, in particular, is known to exacerbate systemic inflammation as evidenced by “priming the lung” with higher serum high mobility group box 1 (HMGB1), higher cytokine levels and enhanced lung injury in a systemic inflammation animal model [21, 22]. Here, HMGB1 is linked to diabetes mellitus.